Document is current

Article History

Received: 10 March 2022

Revised: 22 June 2022

Accepted: 30 June 2022

First Online: 15 July 2022

Declarations

:

: A written consent was obtained for all the participants in this study.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee For Health From Centro Hospitalar Universitário de São João (project 52/2016), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: S.P.: participation in advisory boards for Alimera, Bayer, Novartis, Roche. A.C.: participation in advisory boards for Allergan, Alimera, Bayer, Novartis, and Roche. All the other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.